Product Information

LORAZEPAM 2 MG/ML ORAL CONCENT is a generic product labeled by Amneal Pharmaceuticals LLC, priced at $0.6478 per ML under NDC 65162068784. Its NADAC has been published 678 times since Nov 28, 2013.

FDA first approved this application on Dec 23, 2009. Its Orange Book therapeutic-equivalence code is AA.

LORAZEPAM 2 MG/ML ORAL CONCENT

Lorazepam
$0.6478per ML
DEA Schedule CIV

Strength

2 mg/mL

NDC

65162068784

Classification

Generic

Dosage Form

CONCENTRATE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

LORAZEPAM

Approval Type

Generic (ANDA)

FDA Application

ANDA091383

FDA Approved

12/23/2009

TE Code

AA

On Market Since

2/1/2010

Pharmacological Classes

Benzodiazepine
Benzodiazepines

Price Statistics

The NADAC for LORAZEPAM 2 MG/ML ORAL CONCENT has been published 678 times since Nov 28, 2013, and over the history we have for it it has declined 4.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.6478 per ML
All-time high$0.8544 (Mar 12, 2014)
All-time low$0.5070 (May 23, 2018)
52-week high$0.6928
52-week low$0.6214
Median price$0.6266
Average price$0.6295
Largest weekly change+21.5% (May 17, 2023)
Weeks tracked678
Tracking sinceNov 28, 2013

Price History

1W

-3.8%

1M

-5.6%

3M

-6.5%

6M

+2.5%

1Y

-2.4%

3Y

-2.9%

5Y

+0.8%

All

-4.5%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

1 alternative • Same active ingredient

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of LORAZEPAM 2 MG/ML ORAL CONCENT?

The current National Average Drug Acquisition Cost (NADAC) for LORAZEPAM 2 MG/ML ORAL CONCENT, manufactured by Amneal Pharmaceuticals LLC, is $0.6478 per ML (NDC 65162068784), effective Nov 18, 2026.

How has the price of LORAZEPAM 2 MG/ML ORAL CONCENT changed over time?

Over the history we have for it, the NADAC for LORAZEPAM 2 MG/ML ORAL CONCENT has declined 4.5%. It has been tracked across 678 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for LORAZEPAM 2 MG/ML ORAL CONCENT?

Since Nov 28, 2013, the NADAC for LORAZEPAM 2 MG/ML ORAL CONCENT has ranged from a low of $0.5070 (May 23, 2018) to a high of $0.8544 (Mar 12, 2014), with a median of $0.6266 per ML.

Are there cheaper alternatives to LORAZEPAM 2 MG/ML ORAL CONCENT?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as LORAZEPAM 2 MG/ML ORAL CONCENT in a comparable dosage form, but none are currently priced below it.

Who manufactures LORAZEPAM 2 MG/ML ORAL CONCENT?

LORAZEPAM 2 MG/ML ORAL CONCENT (NDC 65162068784) is labeled by Amneal Pharmaceuticals LLC, and CMS classifies it as a generic product.